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ABCB6 resides in melanosomes and regulates early steps of melanogenesis required for 
PMEL amyloid matrix formation. 
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Abstract  
Genetically inheritable pigmentation defects provide a unique opportunity to reveal the function 
of proteins contributing to melanogenesis. Dyschromatosis universalis hereditaria (DUH) is a 
rare pigmentary genodermatosis associated with mutations in the ABCB6 gene. Here we use 
optical and electron microscopy imaging combined with biochemical tools to investigate the 
localization and function of ABCB6 in pigment cells. We show that ABCB6 localizes to the 
membrane of early melanosomes and lysosomes of the human melanocytic cell line MNT-1. 
Depletion of ABCB6 by siRNA impaired PMEL amyloidogenesis in early melanosomes and 
induced aberrant accumulation of multilamellar aggregates in pigmented melanosomes. PMEL 
fibril formation and normal maturation of pigmented melanosomes could be restored by the 
overexpression of wild-type ABCB6 but not by variants containing an inactivating catalytic 
mutation (K629M) or the G579E DUH mutation. In line with the impairment of PMEL matrix 
formation in the absence of ABCB6, morphological analysis of the retinal pigment epithelium 
of ABCB6 knockout mice revealed a significant decrease of melanosome numbers. Our study 
extends the localization of ABCB6 to melanosomes, suggesting a potential link between the 
function of ABCB6 and the etiology of DUH to amyloid formation in pigment cells. 
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Highlights 
Mutations of the ABCB6 gene cause a rare pigmentary defect but its role in pigmentation 
remains to be clarified.  
ABCB6 resides in the early melanosomes and lysosomes of pigment cells.  
ABCB6 plays a key role in the early steps of melanogenesis producing PMEL amyloid fibrils. 
Our study provides a possible explanation linking ABCB6 mutations to the DUH phenotype.  
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Introduction 
Hereditary pigmentation defects are caused by mutations in genes that code for key factors 
involved in melanocyte-specific but also ubiquitous pathways. Each genetic pigmentation 
disorder offers new clues to the understanding of the pigmentation process encompassing as 
diverse mechanisms as the generation of melanosomes, melanin synthesis, the transfer of 
melanin to the keratinocytes or the survival of melanocytes. More than 127 loci are known to 
affect pigmentation in mouse1 but the function of the gene products or their implication in 
pigmentation is only partially understood. Morphological and biochemical studies that revealed 
mechanisms orchestrating the formation and trafficking of melanosomes have shed light on 
essential processes whose alterations result in general pigmentation defects2.  
Dyschromatosis universalis hereditaria (DUH) is a pigmentary genodermatosis characterized 
by a mixture of hyper- and hypo-pigmented macules distributed over the body. The only 
causative gene reported for DUH encodes the ATP binding cassette (ABC) transporter 
subfamily member B6 (ABCB6)3–5. ABC transporters are large membrane-spanning 
multidomain proteins promoting the ATP-dependent transmembrane transport of a vast array 
of biological compounds, including drugs, bile acids, peptides, steroids, ions, and 
phospholipids. The human genome encodes 48 ABC transporters, which have been grouped 
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into subfamilies labeled A-G. In addition to the well characterized ABCB1 (P-glycoprotein), 
responsible for the multidrug resistance phenotype of cancer cells,6 the ABCB subfamily 
contains seven half transporters, including the mitochondrial ABC transporters ABCB7, 8 and 
10. ABCB6 is expressed in various cell types including hepatocytes, reticulocytes7 and pigment 
cells such as skin melanocytes and the retinal pigment epithelium (RPE)8. In erythrocytes, 
ABCB6 was shown to form the molecular basis of a rare blood group system Langereis (Lan)7,9. 
Interestingly, Lan-negative individuals7 and mice lacking ABCB6 are normal, devoid of any 
pigmentation phenotype10,11. 
ABCB6 was first localized to the outer membrane of mitochondria12. Later, several studies 
suggested extramitochondrial localizations including the plasma membrane13 or the 
endolysosomal compartment14,15,16,17. Considering the link of ABCB6 to DUH, this latter 
localization is of particular interest, because melanosomes are lysosome-related organelles 
(LRO) of endosomal origin1,5. Melanosome biogenesis proceeds through two independent 
steps. The first step is initiated in a compartment corresponding to early endosomes (stage I 
melanosomes), where the premelanosomal protein PMEL is processed into amyloid fibrils 
forming the intraluminal matrix of stage II melanosomes18. The formation of PMEL fibrils is 
dependent on the correct trafficking of PMEL to stage I melanosomes,19,20 where PMEL is 
cleaved by several proteases to release luminal amyloidogenic fragments21–23.  These fragments 
are sorted onto intraluminal vesicles that are thought to act as nucleating platforms orchestrating 
mature PMEL fibril formation24,25.  Interestingly, PMEL fibrils adopt a typical amyloid-like 
structure and the mechanisms involved in PMEL fibril formation are analogous to the Amyloid 
Precursor Protein derived pathological amyloid fibril formation in Alzheimer disease. PMEL-
derived amyloid structures belong to the emerging category of physiological amyloids that have 
beneficial cellular functions18. Once formed, amyloid fibrils provide a template for the synthesis 
and storage of eumelanin pigment in later melanosomal stages (stage III and IV, referred here 
as pigmented melanosomes)2,7,8. Mutations affecting PMEL trafficking or processing can be 
associated with melanin defects 22,26,27. In such cases, hypopigmentation can result from the 
generation of cytotoxic amyloid PMEL fragments affecting melanocyte survival or from the 
reduced stability and/or secretion of pigmented melanosomes18. However, studies have also 
shown that PMEL fibril formation and melanin synthesis can be independent. For example, 
melanocytes devoid of PMEL expression still have normal pigment levels28 and altered PMEL 
fibrillation in absence of ApoE expression does not affect later stage of melanogenesis25. 
Whereas melanosomes and lysosomes are distinct organelles in melanocytes,20 recent studies 
have proposed that lysosomes are required for correct PMEL amyloid matrix formation29–31, 
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suggesting a potential role for lysosomal proteins such as ABCB6 in early steps of melanosome 
biogenesis. Although mutations of the ABCB6 gene have been linked to a variety of 
pathophysiological conditions ranging from ocular coloboma to porphyria32,33, its precise 
cellular localization and function is not understood. At present, it is unknown if the reported 
mitochondrial localization of ABCB6 is dependent on specific conditions and cell types related 
to porphyrin synthesis. Furthermore, the physiological function of ABCB6 in the endo-
lysosomal continuum remains to be clarified. In an attempt to understand the link between 
ABCB6 mutations and the DUH phenotype, we investigated the subcellular localization and 
function of ABCB6 in a human melanocytic cell line, MNT-120,34. Our results unequivocally 
show that ABCB6 resides in the lysosomes and early melanosomes of MNT-1 cells.  
Ultrastructural analysis of MNT-1 cells depleted for ABCB6 or expressing mutant ABCB6 
variants suggests that ABCB6 regulates early steps of melanosome biogenesis required for the 
generation of PMEL amyloid fibrils.  
 
Results 
ABCB6 localizes to early melanosomes and lysosomes in the human melanocytic cell line 
MNT1 
To assess the localization of ABCB6 in pigment cells, we turned to the widely used human 
melanocytic cell line MNT-1, which contains the complete machinery needed for efficient 
melanogenesis20. As a first approach, we probed the total cell lysate and various cellular 
fractions21 with antibodies recognizing ABCB6 and organelle marker proteins. The ABCB6 
signal was present in the cell lysate, and in particular in the light material fraction containing 
early melanosomes and other endo-lysosomal compartments21. Albeit to a lesser extent, 
ABCB6 was also associated with the dense material fraction containing pigmented 
melanosomes, but it was completely absent from exosomes and the detergent insoluble fraction 
that contains only PMEL-derived amyloid fibrils21. Taken together, these results suggest that 
ABCB6 co-fractionates with melanosomes, especially early melanosomes, and does not appear 
in exosomes that correspond to the secreted intraluminal vesicles from endosomes25,35 (Fig 1A). 
Immunocytochemical analysis of MNT1 cells by confocal microscopy showed the absence of 
ABCB6 in mitochondria (labeled by AIF) or the ER (labeled for Calnexin) or the Golgi (labeled 
by RCAS1) (Fig 1B). Further analysis confirmed that the endogenous ABCB6 protein co-
localizes primarily with the lysosomal compartments (labeled by LAMP1), and in particular 
with early (stage II) melanosomes (labeled with Nki-beteb and HMB45). Interestingly, very 
early melanosomes, labeled with EEA1, and mature (pigmented) melanosomes positive for the 
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tyrosinase related protein 1 (TRP-1) did not contain appreciable ABCB6 levels, suggesting that 
ABCB6 is specifically associated with early maturing melanosomes containing processed 
amyloidogenic PMEL domain fragments and PMEL fibrils, recognized by the Nki-beteb and 
HMB45 antibodies36,20 (Fig 1B,C). The intracellular localization of the endogenous ABCB6 
protein was refined by immunogold labeling of ultrathin cryosections of MNT-1 cells. Electron 
microscopy pictures showed a clear enrichment of ABCB6 in early maturing melanosomes 
containing Nki-beteb-labeled material likely corresponding to fibrils, but also its localization 
in tubulo-vesicular structures containing dense material that we identified as lysosomes (Fig 
1D-E). Interestingly, ABCB6 was present on the limiting membrane of early melanosomes, in 
line with its absence on intraluminal vesicles destined to be secreted as exosomes (Fig 1A). 
Thus, these three different methods yielded congruent results, indicating that in MNT-1 cells, 
endogenous ABCB6 is localized to lysosomes and early melanosomes. This expression pattern 
is exactly at the crossroad between the endo-lysosomal and the melanosome biogenesis 
pathways where PMEL fibril formation is initiated2.  
 
Downregulation of ABCB6 by siRNA perturbs early steps of PMEL amyloid formation 
without eliminating melanogenesis  
To characterize the functional relevance of ABCB6 in melanogenesis, we tested the effect of 6 
different siRNA constructs on the expression of endogenous ABCB6 protein and the melanin 
content of the cells. While ABCB6 depletion did not affect significantly melanin content (Fig 
2A-B), the individual siRNA constructs induced highly variable changes in cellular melanin 
contents (Fig S1A-B), suggesting that the melanogenesis pathway might have been disturbed. 
We next investigated trafficking of melanosomal proteins into their respective melanosomal 
compartments, which is a crucial task during melanogenesis. During normal melanosomal 
maturation, PMEL is targeted to early melanosomes where it generates amyloid fibrils. Further 
maturation of melanosomes includes targeting of TRP-1 and other melanogenic enzymes to late 
stage melanosomes, allowing the production and accumulation of melanin that masks the 
PMEL epitopes in late stage melanosomes. Immunofluorescence assays using confocal 
microscopy revealed that, despite efficient depletion of ABCB6 (Fig 2A, Fig S1A), both 
proteins were properly targeted to distinct compartments as in the control situation, indicating 
proper trafficking of melanosomal proteins and the intact maturation of melanosomes (Fig 2C).  
Localization in lysosomes and early melanosomes indicates that ABCB6 may influence initial 
steps of melanosome biogenesis 27,37. We therefore looked for possible defects in the proteolytic 
processing of PMEL, which have been associated with altered pigmentation22,28. Formation of 
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PMEL-derived fibrils requires the sequential processing of PMEL22,18. Using an antibody raised 
against the cytoplasmic tail of PMEL (PMEL-Cter), we followed the levels of the 
unglycosylated, full length form of PMEL (P1); the transmembrane M-beta fragment resulting 
from the first cleavage of P1 by proprotein convertase (MBeta)21,38; and the  membrane-
associated C-terminal fragment (CTF) generated by the processing of the M-beta fragment by 
the beta-site APP-cleaving enzyme 2 (BACE2) 27. PMEL CTF is further processed by the 
gamma-secretase complex containing presenillin-2 in the lysosomes of pigment cells39. 
Importantly, BACE2-mediated cleavage releases the M-alpha fragment, the amyloidogenic 
luminal domain of PMEL, into the melanosome lumen27. The M-alpha fragment is 
proteolytically processed to produce the amyloidogenic peptides that finally assemble into 
detergent insoluble protofibrils and fibrils recognized by the HMB45 and I51 antibodies 38. 
While the steady state levels of the unglycosylated, full length form of PMEL did not change, 
downregulation of ABCB6 resulted in an increase of M-beta and CTF levels, suggesting that 
ABCB6 depletion hinders global PMEL processing without specifically inhibiting any of the 
cleavage steps (Fig 2D, Fig S1C)1. We investigated further processing of the luminal 
amyloidogenic fragments of PMEL by probing the detergent insoluble fraction of MNT-1 cells 
with HMB45 and I51 antibodies27,25. Depletion of ABCB6 by 6 different siRNA constructs (all 
resulting in the effective downregulation of ABCB6 levels) induced a variable decrease of the 
steady state levels of PMEL amyloid peptides (Fig 2E and Fig S1D and E). This suggested 
that depletion of ABCB6 may impair the generation of amyloidogenic fragments or affect their 
fibrillation leading to the generation of aberrant aggregates of PMEL fragments that were not 
retrieved by classical SDS-PAGE Western-blot analysis. 
Electron microscopy (EM) allows the ultrastructural analysis of PMEL amyloid matrix 
formation. Ultrathin sections of resin embedded MNT-1 cells revealed that depletion of ABCB6 
did not change the global ratio between pigmented and unpigmented melanosomes  or the 
number of lysosomes (Fig 2 F,G). However, loss of ABCB6 resulted in a significant decrease 
in the number of early melanosomes displaying normal PMEL fibril formation (Fig 2F-G) and 
the striking presence of large aggregates filling the lumen of early and late melanosomes 
(identified by the presence of clathrin coats and melanized fibrils, respectively) (Fig 2F inset)). 
To our knowledge, similar structures have never been reported in melanosomes. The aggregates 
are reminiscent of EM structures observed in lysosomal storage disorders such as ceroid 
lipofuscinosis40, with a more complex, hydrangea-like structure suggestive of lipid-protein 
complexes. Thus, the EM images confirmed that PMEL fibril formation is altered in absence 
of ABCB6, leading to the formation of aberrant aggregates in the lumen of early melanosomes. 
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Such aggregates, once formed in early melanosomes, likely persist and accumulate during their 
maturation into pigmented melanosomes. 
 
ABCB6 mutations prevent the rescue of normal amyloid fibril formation 
To study the potential of ABCB6 to rescue the above described ultrastructural phenotype, we 
stably transfected MNT-1 cells with constructs encoding either wild-type (WT), an inactive 
(K629M)17,41 or a DUH mutant (G579E) ABCB6 variant42. Localization of WT, K629M or 
G579E ABCB6 was assessed by immunofluorescence confocal microscopy (Fig3A). Overall, 
the exogenously expressed ABCB6 variants displayed a similar localization pattern as the 
endogenous ABCB6 protein, although the association of the DUH mutant variant with markers 
of the amyloidogenic luminal domain of PMEL and the PMEL fibrils was less pronounced 
(Fig3B). At the same time, cells expressing the DUH mutant variant displayed a different 
staining pattern for HMB45 and Nki-beteb suggesting that PMEL luminal fragments were 
produced but their aggregation into fibrils might have been affected (Fig3A).  
Next, parental MNT-1 cells, as well as MNT-1 cells stably expressing ABCB6 variants were 
depleted for endogenous ABCB6 using an siRNA construct targeting a non-coding region of 
the gene (siABCB6#2). Western blot analysis of MNT-1 cell lysates revealed that efficient 
targeting of endogenous ABCB6 still allowed the overexpression of the different ABCB6 
variants (Fig 3C) providing a model system for rescue experiments. Immunofluorescence 
assays using antibodies against PMEL and TRP-1 revealed normal localization of both proteins 
(Fig 3D), excluding impaired trafficking of PMEL and the melanogenic enzyme TRP-1 to early 
and late melanosomes, respectively. As observed for ABCB6 depletion, melanin content was 
not consistently affected (Fig S1F).  
Ultrathin cryo-sections of MNT-1 cells immunogold labeled for ABCB6 and the PMEL 
amyloidogenic domain showed a clear enrichment of wild-type ABCB6 in early melanosomes 
containing Nki-beteb-labeled fibrils, as shown for the endogenous protein (Fig 4A, left panel). 
Morphological analysis of ultrathin sections of resin embedded MNT-1 cells revealed that 
expression of wild-type ABCB6 restored the number and morphology of stage II melanosomes, 
suggesting the rescue of PMEL fibril formation (Fig 4B, left panel). At the same time, 
overexpression of wild-type ABCB6 resulted in a significant increase of the number of 
lyososomes (Fig 4C), indicated by the increased presence of typical multilamellar fingerprint 
structures. Notably, lamellar and multilamellar structures could be also observed in a minor 
fraction of early and mature melanosomes (Fig 4B, left panel inset).  
  8 
Images obtained with the two mutant ABCB6 variants were strikingly different. In both cases, 
a significant accumulation of aberrant early melanosomes and a decrease of pigmented 
melanosomes was observed. On immunogold labeled ultrathin cryosections, both mutants were 
localized to PMEL-positive endocytic structures and lysosomes (Fig 4A, middle and right 
panel), confirming that these mutations did not affect intracellular trafficking. In the case of the 
catalytically inactive ABCB6 variant (K629M), stage II melanosomes contained unstructured 
aggregates of various size, staining positive for PMEL luminal domain (Fig 4A, middle panel). 
Ultrathin sections of resin embedded MNT-1 cells overexpressing the K629M mutant 
confirmed a complete disorganization of PMEL fibrils in these melanosomes (Fig 4B, middle 
panel; and Fig 4C). In line with the presence of unstructured PMEL aggregates, the K629M 
mutant induced the generation and accumulation of aberrant compartments, likely stage II 
compartments (Fig 4B, middle panel inset) full of protofibrils or small aggregates unable to 
form fully mature amyloid fibrils, but devoid of the hydrangea-like structures observed in the 
siABCB6 condition. The DUH mutant (G579E) was localized in endosomal compartments 
containing intraluminal vesicles and unstructured aggregates staining positive for the PMEL 
luminal domain, suggesting perturbed formation of PMEL fibrils and a defect in the maturation 
of early melanosomes (Fig 4A, right panel). Ultrathin sections of resin embedded MNT-1 cells 
overexpressing the G579E mutant confirmed impaired fibril formation. The DUH mutant 
displayed an accumulation of aberrant early, and to a less extent late melanosomes, containing 
intralumenal multilamellar structures, as observed in cells overexpressing WT ABCB6, and 
hydrangea-like structures, as observed in ABCB6-depleted cells (Fig 4B, right panel inset). 
These results clearly show that in contrast to the wild-type protein, the mutant ABCB6 variants 
were unable to rescue PMEL fibril formation, failing to restore the number of normal early 
melanosomes depleted by the downregulation of ABCB6, and inducing instead an 
accumulation of aberrant stage II melanosomes showing signs of improper PMEL fibril 
formation. Deeper analysis of the electron micrographs allowed us to further investigate 
molecular mechanisms controlling PMEL fibril formation. Once cleaved, the luminal domain 
of PMEL is sorted to intraluminal vesicles that are thought to act as amyloid nucleating seeds 
of PMEL fibrils24,43. Ultrathin sections of resin-embedded MNT-1 cells revealed that in all 
conditions, intraluminal vesicles were still generated in early melanosomes (Fig 4D top panels). 
Immunogold labeling of cryosections of the same cells with an antibody recognizing the PMEL 
fibril epitope (Nki-beteb) revealed that in all conditions, the luminal domain of PMEL was 
released in the lumen of the compartment and was still associated with intraluminal vesicles 
(Fig 4D, bottom panels). Taken together, these data clearly show that ABCB6 influences the 
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aggregation of PMEL amyloidogenic fragments into fibrils but not former steps involved in 
PMEL fibril formation. Albeit to a different extent, both the depletion and mutation of ABCB6 
resulted in the disorganization of PMEL fibrils, preventing normal maturation and organization 
of the amyloid matrix.  
 
Genetic disruption of Abcb6 results in subtle ultrastructural changes of retinal pigmented 
epithelium in mice. 
Melanogenesis in vivo can be morphologically analyzed by conventional electron microscopy 
(EM) analysis of the retinal pigment epithelium (RPE) of the eyes 25. To assess the role of 
ABCB6 in RPE pigmentation, we determined the structure of RPE by examining the retinal 
ultrastructure of 6-month-old ABCB6-/-, ABCB6-/+ and ABCB6+/+ mice. Compared to the normal 
ultrastructure of wild type (WT) RPE, the density of melanosomes in the RPE of ABCB6+/- and 
ABCB6-/- mice was significantly lower (Fig 5 A,B). A similar decrease in melanosome numbers 
was described in conditions associated with a defect in PMEL fibril formation and the 
aggregation of aberrant and toxic PMEL amyloidogenic fragments damaging melanosome 
integrity26. However, the shape of melanosomes, expressed as a ratio between width and length, 
was normal in ABCB6 knockout mice, contrary to the rounded morphology of melanosomes in 
mouse strains with impaired PMEL fibril formation 22,44,45 (Fig 5C). These results confirmed 
the in vivo relevance of ABCB6 in melanosome biogenesis in the RPE. 
 
Discussion   
Dyschromatosis Universalis Hereditaria (DUH) is a rare autosomal dominant genodermatosis 
characterized by asymptomatic hyper- and hypo-pigmented macules that appear in infancy or 
early childhood. The etiopathology of DUH is not known. Lesions show a focal increase or 
decrease in melanin and melanosome content of melanocytes and keratinocytes of the basal 
layer, which is believed to be the consequence of a defect in melanosome production and/or 
distribution, rather than a disorder of melanocyte numbers42,46,47. Several associated conditions 
have been reported, including ocular abnormalities, photosensitivity, neurosensory hearing 
defects, mental retardation and erythrocyte, platelet and tryptophan metabolism 
abnormalities48. Although the role of environmental factors cannot be excluded, at present it is 
not clear if these conditions represent a single disease entity, especially because DUH patients 
with ABCB6 mutations do not exhibit any of the additional abnormalities.  
The pigmentation defect of DUH patients led us to investigate the role of ABCB6 in 
melanogenesis. We are far from attributing each melanosomal protein with a defined function 
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in melanogenesis or melanosome secretion. However, proteins implicated in hereditary 
pigmentation defects often reveal key mechanisms. In this study, we used the MNT-1 cell line 
as a pigment cell model to characterize the role of ABCB6 in melanogenesis. MNT-1 is a highly 
pigmented human melanoma cell line that is widely used as a model system as it has conserved 
the complete machinery to continuously produce all melanosome stages, from the generation 
of PMEL amyloid fibrils to the synthesis of eumelanin2,20. Several reports have used this cell 
line for localization studies and to reveal the role of key proteins involved in intracellular 
trafficking2749, proteolytic cleavage22 and signaling pathways50 regulating melanogenesis. 
Using complementary methods, we show that the endogenous ABCB6 protein is localized to 
the lysosomes and early melanosomes of MNT-1 cells. Our results confirm previous  
localization of ABCB6 in the endolysosomal continuum 16,17 and indicate that ABCB6 does not 
localize to the mitochondria of MNT-1 cells. Several ABC transporters have been associated 
with melanocytes and melanoma cells51,52, and mass spectrometry analysis already suggested 
the presence of ABCB6 in purified early melanosomes 53, but to our knowledge, this is the first 
study to unequivocally demonstrate the presence of an ABC transporter in the membrane of 
melanosomes. While ABCB6 is present on exosomes of reticulocytes 16, it was not observed in 
the exosome fraction of MNT-1 cells, in line with known differences in the sorting mechanisms 
of melanocytes and reticulocytes35. 
Melanosomes and lysosomes are distinct compartments in MNT-1 cells20, although lysosomes 
are thought to contribute to PMEL CTF processing39 and to PMEL fibril formation during early 
melanogenesis29–31 by a yet unknown mechanism. In a first attempt to understand the role of 
ABCB6 in melanogenesis, we depleted ABCB6 by siRNA in MNT-1 cells. Overall melanin 
levels, the sorting of melanosomal proteins, the formation of intraluminal vesicles appeared 
normal, but the cleavage of the full length PMEL was slightly affected and the apparent steady 
state levels of PMEL amyloidogenic fragments were significantly decreased (Fig 2 D, E). 
Modulation of amyloidogenic PMEL fragment levels can result from a defect of PMEL 
cleavage22, PMEL sorting27, an inhibition of lysosomal protease activity39, or the loss of 
melanosomal identity44. In all these conditions, the decrease of amyloidogenic PMEL fragment 
levels was associated with disturbed PMEL fibril formation. Strikingly, morphological analysis 
at the ultrastructural level revealed the appearance of large aggregates displaying a hydrangea-
like morphology in early and mature melanosomes of cells depleted for ABCB6 or expressing 
ABCB6 mutants. Based on their morphology, the aberrant structures are likely composed of 
proteo-lipid aggregates, corresponding to the unstructured aggregates containing PMEL 
luminal domain, as observed in cryosections of cells embedded in gelatin for immunogold 
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labeling. We interpret these results to suggest that defects of ABCB6 levels and/or function 
result in the impaired assembly of PMEL amyloidogenic fragments into well-organized fibrils. 
Ultimately, impaired assembly leads to aberrant aggregates that could not be detected by SDS-
PAGE and Western blotting, explaining the apparent decrease of steady state levels of PMEL 
amyloidogenic fragments, but that were clearly visible on the EM images. Deeper biochemical 
investigations are required to characterize the composition of the aggregates, which could 
reveal the molecular basis of the pathological PMEL aggregation.  
The clear defect in amyloid formation observed in ABCB6-depleted MNT-1 cells is at odds 
with the normal phenotype of the ABCB6 knockout mice and the lack of pigmentation 
abnormalities in Lan-negative individuals54. Normal melanogenesis may be explained by 
compensatory mechanisms, or in the case of knockout mice the lack of external stress factors 
in the well-controlled laboratory environment, where the function of the ABC transporter-based 
“chemoimmunity network” responsible for detoxification may be less relevant55. Importantly, 
in contrast to human skin, mice skin does not contain melanocytes, which are only present in 
hair follicles56. Therefore, the effect of ABCB6 depletion in the human melanocyte model 
MNT-1 may not be relevant for mice pigmentation. Here we show that beneath the normal fur 
of ABCB6 -/- mice, there are subtle but significant differences in the ultrastructure of the retinal 
pigment epithelium, where formation of melanosomes is restricted to a brief developmental 
period57. We attribute the decrease of melanosome density in the RPE of ABCB6 +/- and -/- mice 
to an early defect in melanosomal biogenesis that would impair their formation or integrity. 
Similar phenotypes were described in conditions associated with a defect in PMEL fibril 
formation and the aggregation of aberrant and toxic PMEL amyloidogenic fragments damaging 
melanosome integrity26. However, unlike conditions where PMEL fibril formation was 
completely impaired 22,44,45,  the shape of the remaining melanosomes in the RPE of ABCB6 
knockout mice was not abnormal.   
Using an siRNA construct targeting a non-coding region and the lentiviral system to 
downregulate and overexpress ABCB6, respectively, we were able to study the potential of 
ABCB6 variants to rescue MNT1 cells from the ABCB6-depletion phenotype. We show that 
rescue with the wild-type form of ABCB6 almost fully restores the generation of PMEL fibrils, 
although it also increased the generation of multilamellar lysosomal structures. Mutation of the 
catalytic Walker A lysine residue is known to impair the function of ABC transporters58, and 
several DUH mutations are predicted to be deleterious – including the G579E mutation, which 
affects a non-conserved amino acid in the cytoplasmic nucleotide binding domain59. Contrary 
to former reports showing accumulation in the Golgi4, ABCB6 G579E was properly targeted 
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to melanosomes. Since neither the K629M nor the G579E mutant ABCB6 variant was able to 
restore normal biogenesis of PMEL fibrils and both induced the accumulation of unpigmented 
aberrant melanosomes, we believe it is likely that the G579E mutation impairs the function of 
ABCB6. Considering the dominant inheritance of DUH and the homodimerisation of 
ABCB616,60, a straightforward explanation is that DUH mutations antagonize the wild-type 
allele through a dominant negative effect.  
How can a defect of PMEL matrix formation lead to the complex pigmentation changes 
observed in DUH patients? The localization of ABCB6 in early melanosomes, the variable 
modulation of melanin levels by anti-ABCB6 siRNA and the morphological changes observed 
by electron microscopy all point toward a defect in early melanogenesis involving PMEL 
amyloid fibril formation. Subtle defects in PMEL fibril formation are known to result in altered 
melanin deposition, affecting the integrity of mature melanosomes and ultimately leading to 
variable changes in global melanin concentrations22,26,28. Similarly to the ABCB6-null 
phenotype, complete depletion of PMEL has only a subtle effect on the coat color of mice28, 
while silver mice expressing a truncated version of PMEL are unable to produce a functional 
matrix26, and BACE2 knock out mice that fail to process PMEL22 display a grey coat color. The 
hypopigmented areas characteristic to DUH may result from a defect in the maturation of early 
melanosomes or from the compromised integrity of pigmented melanosomes due to the 
accumulation of PMEL toxic oligomers36.  
The DUH mutation results in the accumulation of the amyloid PMEL luminal domain in 
multivesicular compartments, and loss of ABCB6 induces the accumulation of hydrangea-like 
structures. Based on these results we hypothesize that ABCB6 regulates critical steps in the 
formation of the PMEL matrix. However, the DUH mutation did not abolish processing of 
PMEL, nor the sorting of its luminal domain onto intraluminal vesicles (Fig 4D). Rather, the 
defect seems to be associated with the last steps of fibrillation where the amyloidogenic PMEL 
fragments turn into mature fibrils on the surface of intraluminal vesicles24. Similarly, the major 
defect in ABCB6-depleted cells is associated with the aberrant aggregation of amyloid PMEL 
luminal domains on the surface of intraluminal vesicles. Based on these observations it is 
tempting to speculate that the function of ABCB6 is required for maintaining the intraluminal 
homeostasis of the maturing early melanosome, which is needed for efficient fibrillation and 
matrix formation. 
The ABCB6-related morphological alterations also raise the possibility that the observed 
phenotype is due to an indirect effect, mediated by lysosomes, which are thought to contribute 
to early melanosome biogenesis and the control of the fibrillation of PMEL amyloidogenic 
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domains29–31. Given the increased number of lysosomes and the presence of lysosomal 
structures in the melanosomes of cells overexpressing wild-type ABCB6 or the G579E mutant, 
it is tempting to speculate that ABCB6 may regulate lysosome-related processes. Lysosomal 
proteases have been reported to process different fragments of PMEL during early steps of 
melanogenesis29–31,39. Thus, ABCB6 may either regulate lysosome activity or support potential 
inter-organelle interactions between lysosomes and early melanosomes that remain to be 
demonstrated. Finally, we cannot exclude the possibility that the DUH phenotype is due to a 
defect in the transfer of mature melanosomes to keratinocytes- this hypothesis will need testing 
in a different experimental setup, as pigmentation of the fur coat is not an appropriate model 
for melanosome transfer56. Once transferred to keratinocytes, melanosomes are either stored in 
non-degradative compartments61,62 or are degraded by lysosomal hydrolases37,63.  It is also 
possible that ABCB6 influences these events through its expression and function in lysosomes 
of keratinocytes. A role in early melanogenesis in melanocytes and melanosome 
storage/degradation in keratinocytes are not mutually exclusive, and may explain the 
morphology of DUH skin biopsies, which indicated a normal number of intact melanocytes in 
both the hypo- and hyper-pigmented skin areas42, a lower number of mature melanosomes in 
hypo-pigmented macules and an accumulation of pigmented melanosomes in melanocytes and 
in keratinocytes in hyper-pigmented macules. 
In summary, our study shows that ABCB6 is expressed in lysosomes and early melanosomes of 
pigment cells and regulate early steps of melanogenesis. Understanding the relevance of 
ABCB6 in melanogenesis will require a better understanding of the function of ABCB6 in the 
endolysosomal system. Ongoing work in our laboratories focuses on the role of ABCB6 in the 
formation of PMEL amyloid fibrils under normal or pathologic conditions.  
 
 
 
Glossary 
Pigmentation: All processes related to the acquisition or generation of pigment, notably 
melanin. 
Melanin: pigments (from yellow to black) that are produced by melanocytes and retinal 
pigment epithelium among other cell types.  
Melanosomes: intracellular compartment of pigment cells, also called lysosome-related 
organelles. 
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Functional Amyloid: protein or peptides that adopt or display a beta-sheet enriched structures 
and forms insoluble organized structures, often as fibrils. Contrary to pathological amyloids, 
they serve physiological purpose. 
ABC (ATP-Binding Cassette) transporters: A superfamily of carrier proteins containing  two 
highly conserved ATP-binding cassettes, promoting the active transmembrane transport of a 
large array of molecules. 
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Figure Legends: 
Figure 1. Subcellular localization of the endogenous ABCB6 protein in MNT-1 cells.  
A. Total cellular lysates, the insoluble fraction (Pmel fibrils), light material fraction (LMF, early 
melanosomes), dense material fraction (DMF, mature melanosomes) and the exosomes were 
isolated from MNT-1 cells as described in the Materials and methods section.  Cellular fractions 
were analysed by Western-blotting using antibodies raised against specific markers of 
exosomes (Alix), PMEL fibrils (HMB45) mature melanosomes (TRP-1), and ABCB6. Tubulin 
is shown as a loading control.  
B. Determination of the subcellular localization of ABCB6 by immunofluorescence labelling 
and laser-scanning confocal microscopy. Expression of the endogenous ABCB6 protein in 
MNT-1 cells was visualized by the OSK43 ABCB6 antibody (green); nuclei were labelled with 
Hoechst 33342 (blue); organelles were labelled with specific markers (red): ER (Calnexin), 
Golgi (RCAS1), mitochondria (AIF), early endosomes (EEA1), lysosomes (LAMP1). Non-
pigmented melanosomes were labelled using an antibody directed against the luminal domain 
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of PMEL (Nki-bteb) and HMB45; pigmented melanosomes were stained with TRP-1. Scale 
bar: 10µm. 
C. Pearson's correlation coefficients for colocalization of ABCB6 with organelle-specific 
markers shown in B. 
D. Top and bottom panels. Ultrathin cryosections of MNT-1 cells were double immunogold 
labelled for PMEL luminal domain (Nki-beteb, PAG 10nm) and ABCB6 (PAG 15nm). Arrows 
indicate colocalization of endogenous ABCB6 and PMEL in non-pigmented melanosomes; 
asterisks show ABCB6 in lysosomal tubulovesicular structures. Mitochondria are annotated 
with “m”. Scale bar, 500 nm.  
E. Quantification of immunogold labelling of endogenous ABCB6 in MNT-1 cells. Gold 
particles representing labelling for ABCB6 in the EM analysis were counted and assigned to 
the indicated compartments, which were identified based on morphology. Data are presented 
as the mean percentage of total gold particles in each compartment. 
 
 
Figure 2. Effect of ABCB6 depletion on melanogenesis  
A. Downregulation of ABCB6 in MNT-1 cells. Western blot analysis of whole cell lysates 
isolated from MNT-1 cells treated with control or anti-ABCB6 siRNA constructs. Tubulin is 
shown for loading control.  
B. Effect of ABCB6 depletion on the intracellular melanin content of MNT-1 cells. Values 
show averaged melanin levels obtained after treatment with 6 different siRNA constructs 
(MNT1 siABCB6), relative to control (siCtrl). See Supplementary Fig. 2B for details.  
C. Downregulation of ABCB6 does not influence trafficking of melanosomal proteins. 
Subcellular localization of melanosomes was followed by confocal microscopy; using 
antibodies labelling early (Nki-beteb, red) and late melanosomes (TRP-1, green).  Nuclei are 
stained with DAPI (blue). 
D. Detergent-soluble lysates of MNT-1 cells treated with control siRNA (siCtrl) or ABCB6 
siRNA (siABCB6) analysed by immunoblotting, using antibodies against the PMEL C-
terminus (anti-PMEL-C) and tubulin. The different PMEL fragments are annotated on the left.  
E. Detergent-insoluble lysates of MNT-1 cells treated with control siRNA (siCtrl) or ABCB6 
siRNA (siABCB6) were analysed by immunoblotting using antibodies against PMEL 
amyloidogenic domains (anti-PMEL-HMB45 and anti-PMEL-I51) and tubulin.  
F. Representative ultrathin section images of control and ABCB6 depleted MNT-1 cells 
embedded in resin. Black arrowheads indicate stage I melanosomes, white arrowheads point to 
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mature melanosomes containing PMEL fibrils covered by melanin. White arrows point to 
aberrant melanosomes containing a “hydrangea-like” structure (enlarged in the inset). Scale: 1 
µm. 
G. Quantification of endosomal/melanosomal compartments, as defined by the morphology of 
the organelles in conventional EM of control or ABCB6-depleted MNT-1. Values represent the 
percentage of each compartment relative to all of the endosomal/melanosomal compartments 
identified in 20 cell profiles per condition. P values: * = p<0.05, ** = p<0.02, *** = p<0.01. 
 
Figure 3. Expression of ABCB6 variants in MNT-1 cells 
A. Determination of the subcellular localization of ABCB6 by immunofluorescence labelling 
and laser-scanning confocal microscopy. Expression of wild-type (ABCB6 WT), and mutant 
ABCB6 variants (ABCB6 K629M and ABCB6 G579E) was visualized in MNT-1 cells using 
the OSK ABCB6 antibody (green); nuclei were labelled with Hoechst 33342 (blue); organelles 
were labelled with specific markers (red): ER (Calnexin), Golgi (RCAS1), mitochondria (AIF), 
early endosomes (EEA1), lysosomes (LAMP1). Non-pigmented melanosomes were labelled 
using an antibody directed against the luminal domain of PMEL (Nki-beteb and HMB45); 
pigmented melanosomes were stained with TRP-1 (red). Scale bar: 10µm. 
B. Pearson's correlation coefficients for colocalization of ABCB6 variants with the organelle-
specific markers. 
C. Western blot analysis of whole cell lysates isolated from parental MNT-1 cells (Parent), 
MNT-1 cells overexpressing wild-type ABCB6 (ABCB6 WT), a catalytically inactivate form 
of ABCB6 (ABCB6 K629M) or a DUH mutant variant (ABCB6 G579E). Cells were either 
treated with control or anti-ABCB6 siRNA (#2) constructs. Tubulin is shown for loading 
control.  
D. Overexpression of ABCB6 variants does not influence trafficking of melanosomal proteins. 
Subcellular localization of melanosomes was followed by confocal microscopy using 
antibodies labelling early (Nki-beteb, red) and late melanosomes (TRP-1, green).  Nuclei are 
stained with DAPI (blue). 
 
  
Figure 4. Overexpression of DUH mutant ABCB6 fails to rescue the ABCB6 depletion 
phenotype.  
A. Ultrathin cryosections of MNT-1 cells overexpressing ABCB6 WT (left panel), inactive 
ABCB6 (middle panel) or the DUH variant (right panel) were double immunogold labelled for 
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PMEL luminal domain (PAG 10nm) and ABCB6 (PAG 15nm). Arrowheads indicate 
colocalization of ABCB6 and PMEL in non-pigmented melanosomes. Mitochondria are 
annotated with “m”. Scale bar, 500 nm.  
B. Representative ultrathin section images of resin-embedded control and ABCB6 depleted 
MNT-1 cells and MNT-1 cells overexpressing wild-type ABCB6 (lower left panel), inactive 
ABCB6 (lower middle panel) or the DUH variant (lower right panel). Melanosome stages are 
annotated from I to IV; black flowers indicate aberrant pigmented melanosomes containing 
unstructured aggregates along with melanised fibers. White stars indicate aberrant lysosomal 
structures. LD: lipid droplet, V: Vacuole, Lys: Lysosome, M: Mitochondria. Scale bar is 
500nm.  
C. Quantification of endosomal/melanosomal compartments as defined by the morphology of 
the organelles in conventional EM of control or ABCB6-depleted MNT-1 with or without the 
overexpression of wild-type (ABCB6 WT) or mutant ABCB6 variants (ABCB6 K629M, 
ABCB6 G579E). Values represent the percentage of each compartment relative to all 
endosomal/melanosomal compartments identified in 20 cell profiles per condition. P values : * 
= p<0.05, ** = p<0.02, *** = p<0.01 
D. Top panel: Ultrathin cryosections of MNT-1 cells treated with (from left to right) control 
siRNA or anti ABCB6 siRNA; or overexpressing ABCB6 WT, inactive ABCB6, or the DUH 
variant. Arrows point to intraluminal vesicles in early melanosomes. Scale bar, 200 nm. Bottom 
panels: MNT-1 cells treated as shown in the top panels were embedded in gelatin to obtain 
ultrathin cryosections that were double immunogold labelled for PMEL luminal domain (Nki-
beteb, PAG 10nm) and a lysosomal lipid (LBPA, PAG 15nm) for siRNA conditions, or for 
PMEL luminal domain (Nki-beteb, PAG 10nm) and ABCB6 (PAG 15nm) for overexpressing 
conditions. Arrows indicate the presence of PMEL luminal domain on intraluminal vesicles in 
early melanosomes. Scale bar, 200 nm. 
 
Figure 5. Electron microscopy analysis of the retinal ultrastructure of Abcb6-/-, Abcb6 -/+ and 
Abcb6 +/+ mice  
A. EM analysis of resin embedded RPE of adult ABCB6+/+, ABCB6+/- and ABCB6-/- mice 
(Scale bar: 2µm).  
B. Quantification of melanosome number per µm2 of RPE. More than 300 melanosomes were 
quantified in 10 electron micrographs obtained from 3 independent samples for each condition. 
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C. Quantification of the ratio (R) of the maximal width and length of melanosomes for each 
condition. More than 100 melanosomes were measured in 10 electron micrographs obtained 
from 3 independent samples for each condition. 
 
Supplementary Figures.  
A. Quantification of ABCB6 mRNA expression by RT-PCR following treatment of MNT-1 
cells with control siRNA control or siRNA against ABCB6.  
B. Quantification of intracellular melanin contents of MNT-1 cells after treatment with each 
ABCB6 siRNA constructs.  
C. Quantification of PMEL fragments recognized by anti-PMEL-C antibody in the detergent 
soluble fraction (based on band intensities shown in Figure 2D). 
D. Quantification of PMEL amyloidogenic fragments labelled by the HMB45 antibody in the 
detergent insoluble fraction after siRNA treatment of MNT1 cells.  
E. Quantification of PMEL amyloidogenic fragments labelled by the I51 antibody in the 
detergent insoluble fraction after siRNA treatment of MNT1 cells.  
F. Quantification of intracellular melanin contents of MNT-1 cells after overexpression of 
ABCB6 variants with or without treatment with ABCB6 siRNA #2. 
G. Ultrathin cryosections of MNT-1 cells treated with ABCB6 siRNA that were double 
immunogold labelled for PMEL luminal domain (Nki-beteb, PAG 10nm) and ABCB6 (PAG 
15nm). Absence of ABCB6 labeling after ABCB6 siRNA treatment supports the specificity of 
the labelling. White arrows indicate aberrant early melanosomes labelled for PMEL and “m” 
indicates mitochondria. Scale bar, 1 µm. 
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Materials and methods 
 
Cell lines, culture conditions and siRNA transfections 
MNT1 cells were grown in DMEM high glucose medium (4.5 mg/ml Gibco, Grand Island, NY, 
USA)) supplemented with 10% v/v AIM-V, 20% v/v FBS, 1% v/v sodium pyruvate, 1% v/v 
non-essential amino acids, 100 U/ml penicillin and 100 μg/ml streptomycin. MNT1 cells were 
incubated at 37 °C with 5% CO2 and regularly passaged at a density of 80% (1:8 ratio). Cells 
were transfected according to manufacturer’s recommendation with siRNA using 
oligofectamine (Invitrogen). siRNA transfections were performed twice at 48h interval and 
experiments were performed 96h after the first siRNA transfection. Predesigned 
siRNAobtained from Qiagen. siRNA non-targeting control: 5’- AAT TCT CCG AAC GTG 
TCA CGT -3’, siRNA ABCB6#1 (Cat no.SI00080353), siRNA ABCB6#2 (Cat 
no.SI00080360), siRNA ABCB6#3 (Cat no.SI00080374), siRNA ABCB6#4 (Cat 
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no.SI00083731), siRNA ABCB6#5 (Cat no.SI00080873), siRNA ABCB6#6 (Cat 
no.SI00080880). 
 
Mutagenesis 
Wild type ABCB6 (NM_005689) was mutated by mutagenic PCR to generate the G579E DUH 
mutation. Mutagenic primers were the following:  forward: 
gtgaaggaccttcctgaagcagggccccttcgc, reverse: gcgaaggggccctgcttcaggaaggtccttcac. 
 
Expression of ABCB6 variants in MNT-1 cells 
ABCB6-HA13 and its non-functional KM mutant variant (ABCB6-HA KM)16 were expressed 
in MNT1 cells using lentiviral (LV) transduction. All plasmids used in the production of LV 
were obtained via the Addgene Plasmid Repository. To produce recombinant lentiviral 
particles, HEK 293 T human embryonic kidney cells (1.8 × 106 cells on a Petri dish in DMEM–
high glucose supplemented with L-glutamine, Penicillin streptomycin, and 10% FBS ) were 
transfected with (6 µg) pSEW-EF1-ABCB6-PGK-Puromycine expression plasmid, 2.2 µg 
pMD2.G envelope- and 4 µg psPax2 second-generation packaging plasmids, using the CaPO4 
precipitation transfection method. Conditioned medium, containing lentiviral particles, was 
collected 72 h after transfection. The supernatant was cleared by filtration through 0.45-μm 
PVDF membrane filters (Millipore), snap frozen, and stored at −80 °C until further use. 
Transduction of target MNT1 cells was carried out on 6 well plates. The multiplicity of infection 
was approximately 1.  
 
Lysates, cell fractionation and Western blot: 
For Western blots a Triton X-soluble lysate was prepared in 20 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 1% TX-100, 1 mM EDTA, protease inhibitors. The Triton X-insoluble fraction was 
resuspended in 1% SDS, 1% B-mercaptoethanol in PBS containing protease inhibitors, 
incubated for 10 min at RT and then heated for 10 min at 100°C. Light and dense melanosomal 
fractions and exosome isolation were performed as already described25,36. Lysates, fractions 
and exosomes were incubated in sample buffer with or without 350 mM 2-mercapthethanol 
(Sigma), incubated at 60°C for 5 min, and fractionated by SDS-PAGE using Nupage (4-12%) 
Bis-Tris gels (Invitrogen) and transferred onto nitrocellulose membranes (Millipore). The 
membranes were blocked in PBS/Tween 0.1% (PBS/T) with 5% non-fat dried milk, incubated 
with the indicated primary antibody diluted in PBS/T, washed four times in blocking solution, 
and finally incubated with HRP-conjugated secondary antibody followed by washing in PBS/T. 
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Blots were developed using the ECL Plus Western blotting detection system (GE Healthcare) 
according to the manufacturer’s instruction. Signal intensities were quantified with the Image 
J software (National Institute of Health).  
 
Melanin assay 
Cells were disrupted by sonication in 50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 150 mM NaCl, 
1 mM DTT, and protease inhibitors. Pigment was pelleted at 16000g for 15min at 4°C, rinsed 
once in ethanol/ether (1:1), and dissolved in 2M NaOH/20% DMSO at 60°C. Melanin content 
was measured as optical density at 492nm.   
 
Immunofluorescence Microscopy. MNT-1 cells expressing ABCB6 variants were plated in 
Eppendorf 8 well imaging coverglass (#0030742036). Hoechst 33342 was applied to the cells 
20 min prior to fixation, subsequently cells were rinsed in PBS and fixed for 30 min in 4% 
Paraformaldehyde/PBS at room temperature (RT). Fixed cells were quenched for 10min in 
PBS/100mM glycine (quenching buffer), washed with PBS and blocked and permeabilized in 
PBS containing 0.2 mg/ml BSA/0.1% Triton X-100/ 10% Normal Goat Serum (blocking 
buffer). Primary antibody was diluted in PBS containing 0.2mg/ml BSA/0.1%Triton X-100/3% 
Normal Goat Serum (incubation buffer, IB). Cells were incubated with the primary antibody 
overnight at 4°C in a humidified chamber, washed five times in IB, and incubated with the 
corresponding secondary anti-human, anti-rabbit and anti-mouse antibodies conjugated to 
Alexa Fluor 488 or Alexa Fluor 647 diluted in IB for 90 min at RT. Samples were washed five 
times with PBS and subsequently imaged. Confocal images were obtained using a LSM 880 
confocal laser scanning microscope (Carl Zeiss, Inc.) equipped with a Plan-Apochromat 
63×/1.4 NAOil DIC M27objective. Images were acquired in three channels (blue 
[Hoechst33342], green [Alexa Fluor 488], red [Alexa Fluor 647], blue emitting Hoechst 33342 
was excited using the 405nm laser line, green emitting Alexa Fluor 488 was excited using the 
488nm laser line and infrared emitting Alexa Fluor 647 was excited using the 633nm laser line. 
Noise reduction and deconvolution of the images was performed with Huygens Essential 
(Scientific Volume Imaging B.V.). Colocalization analysis was performed with ImageJ 
(National Institute of Health) using the JACoP v2.0 plugin.64 
 
Antibodies and Dyes. 
Monoclonal antibodies and their sources were as follows: Mouse monoclonal Anti-Melanoma 
Associated Antigen 100+/7 kDa [Nki/beteb] antibody (ab34165; used for IFM and EM) and 
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mouse monoclonal Anti-Melanoma [HMB45] antibody (ab787; used for IFM and EM) to 
melanocyte protein (PMEL), mouse monoclonal Anti-TRP-1 [TA99] antibody (ab3312; used 
for IFM and EM) to tyrosinase-related protein 1(TRP1), secondary goat polyclonal antibody to 
human IgG conjugated to DyLight 488 (ab96907) and horseradish peroxidase-conjugated goat 
polyclonal antibodies to rabbit IgG (ab6721) and to mouse IgG (ab6789) were from Abcam. 
Rabbit monoclonal Anti-AIF [D39D2] antibody (#5318) to apoptosis inducing factor, rabbit 
monoclonal Anti-Calnexin [C5C9] antibody (#2679) to Calnexin, rabbit monoclonal Anti-
RCAS1 [D2B6N] to receptor binding cancer antigen expressed on SiSo cells (#12290), rabbit 
monoclonal Anti-EEA1 [C45B10] antibody (#3288) to early endosome antigen 1, rabbit 
monoclonal Anti-LAMP1 [D2D11] antibody (#9091) to lysosome-associated membrane 
protein 1, secondary goat anti-mouse IgG (H+L) F(ab’)2 fragment conjugated to Alexa Fluor 
647 (#4410) and secondary goat anti-rabbit IgG (H+L) F(ab’)2 fragment conjugated to Alexa 
Fluor 647 (#4414) were from Cell Signaling Technology. Secondary goat anti-rabbit IgG (H+L) 
antibody conjugated to Alexa Fluor-488 (A-11034) and Hoechst 33342 (R37605) nuclear 
counterstain were from Thermo Fisher Scientific. The OSK43 antibody was a kind gift from 
Dr Yoshihiko Tani (Japanese Red Cross Osaka Blood Center, Osaka,Japan)65.  ABCB6 ((61.5): 
sc-135726) mouse monoclonal antibody was from Santa Cruz Biotechnology. Affinity-purified 
anti-peptide antibodies recognizing the PMEL N-terminus (α-PMEL-Nter)21, C-terminus (α-
PMEL-Cter) 20 and PKD domain (I51 - kind gift from P. Cresswell, N. Vigneron, and R. M. 
Leonhardt, Yale Univ., New Haven, CT)66 were used as described previously. Mouse anti-
CD63 used for IEM was from Zymed/Invitrogen. Protein A conjugated to 10- or 15-nm gold 
particles (PAG10, PAG15) were from Cell Microscopy Center (Utrecht University Hospital, 
Utrecht University, Utrecht, The Netherlands).  
 
Animal experiments 
Abcb6 -/+ mice were obtained from The Jackson Laboratory following in vitro fertilization of 
C57BL/6J female mice by cryopreserved Abcb6 -/- sperm. Heterozygous and homozygous mice 
were generated by intercrossing F1 heterozygous mice. Genotyping of the mice was performed 
with the following primers:  5'- GGCTGAGGATAGACTAGGCTCTG- 3'; 5'- 
CCTGTGTGTTCATATCACGGCG- 3'; and 5'- CTGCCTTGGGAA AAGCGCCTC- 3'. 
Mice were housed in SPF animal house in cages with free access to water and ad libitum diet. 
All animal procedures were performed in accordance with the EU's most recent directives, as 
approved by the Committee on the Care and Use of Laboratory Animals of the Council on 
Animal Care at the Institute of Enzymology, RCNS in Budapest, Hungary. For the preparation 
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of electron microscopy samples, 6 months old female mice were sacrificed; enucleated eyes 
were immediately fixed in Glutaraldehyde solution (Sigma).  
 
Electron microscopy 
For conventional EM on resin embedded cells, MNT-1 were grown on coverslips, fixed in 2.5% 
glutaraldehyde in 0.1 M cacodylate buffer for 24 h, post-fixed with 1% osmium tetroxide, 
dehydrated in ethanol and embedded in epon as described20. For EM analysis of RPE sections, 
tissues from mice were processed as previsouly22, ultrathin sections of RPE were prepared with 
a Reichert UltracutS ultramicrotome (Leica Microsystems) and contrasted with uranyl acetate 
and lead citrate. For ultrathin cryosectioning and immunogold labeling, cells were fixed in 2% 
PFA, 0.2% glutaraldehyde in 0.1M phosphate buffer pH 7.4. Cells were processed for 
ultracryomicrotomy and immunogold labeled using PAG 10 and PAG 15 as described20. All 
samples were examined with a FEI Tecnai Spirit electron microscope (FEI Company), and 
digital acquisitions were made with a numeric camera (Quemesa; Soft Imaging System).  
Melanosome stages were defined by morphology20,67. Length and width of melanosomes, as 
well as the size were measured using ImageJ software. P values were determined by Student’s 
t-test, unpaired, unequal variance (*p<0.05, **p<0.01, ***p<0.001). 
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